drugset / Trial / NCT01639014
Effect of F2695 on Functional Recovery After Ischemic Stroke
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to assess the efficacy of a new serotonin-norepinephrine reuptake inhibitor (SNRI) nin functional recovery after ischemic stroke.
Timeline
- Start
- 2012-07
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levomilnacipran | Small molecule | 75 mg | — |